BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 2
• 5
• 6
• 7
• 8
• 9
• 12
• 13
• 14
• 15
• 16
• 19
• 20
• 21
• 22
• 23
• 26
• 27
• 28
• 29
• 30

• Alkermes plc Announces a Secondary Offering of 13,900,000 Ordinary Shares Held by Elan Corporation PLC

  March 8, 2012

   · 

  1 min read
• Business

  Boomerang Pharmaceutical Communications Announces Office Move to Accommodate Growth

  March 8, 2012

   · 

  1 min read
• Business

  Covidien Expands Global Research and Development Presence

  March 8, 2012

   · 

  1 min read
• Business

  Enzo Biochem Schedules Teleconference to Discuss 2012 Second Quarter Results on March 13, 2012 at 8:30 AM E.T.

  March 8, 2012

   · 

  1 min read
• 2nd Antibody Engineering Summit 2012 to Open in Beijing This June

  March 8, 2012

   · 

  1 min read
• Biotech Beach

  Metagenics Inc.’ Chief Science Officer, Dr. Jeffrey Bland, Inducted into the New Hope Natural Media 2012 Hall of Legends

  March 8, 2012

   · 

  1 min read
• Pharm Country

  Trianz Solutions Releases a White Paper Entitled “Switching EDC Platforms to Rescue In-flight Clinical Trials”

  March 8, 2012

   · 

  1 min read
• FDA

  Regeneron Pharmaceuticals, Inc. and Bayer HealthCare Announce Approval of EYLEA® (aflibercept) Injection for the Treatment of Wet Age-Related Macular Degeneration in Australia

  March 8, 2012

   · 

  9 min read
• Alkermes plc Prices Secondary Offering of 21,000,000 Ordinary Shares Held by Elan Corporation PLC

  March 8, 2012

   · 

  1 min read
• BioCapital

  Nuvilex Points Toward Cell Encapsulation Technology Future to Expand Stem Cell Use for Late Stage Cancer Treatments

  March 8, 2012

   · 

  1 min read